The stock market was already up double-digits from its lows of April, but now the market has received the dual gifts of a US/China trade deal and a low inflation report. Investors are trying to look beyond the trade deal being temporary as a template for what to expect from other countries negotiating their own trade deals. And now the S&P 500 is actually no longer in the red year-to-date. So, what are investors supposed to do now if they missed this recovery rally?
Oggonomics tracks the daily flow of Wall Street analyst research reports to find hidden gems and to look for new ideas that might have otherwise been overlooked. Even with the recovery of the last 40 days, the trend since March has been for brokerage firms to maintain mostly positive analyst ratings but with severe price target cuts as share prices plunged and as the economic data came down so much.
Most analysts have refrained from massive across the board downgrades, but the flow of upgrades and price target hikes has barely begun. It has been a challenge to find many analyst reports telling investors it’s a good time to jump in after the panic-selling and panic buying. The good news is that there are 15 standout analyst calls that are either upgrades or new initiations with Buy and Outperform ratings and with significant upside calls to the price targets.
Oggonomics always reminds its readers that no analyst report should ever be the sole basis to buy or sell a stock. Analysts can get their thesis wrong like the rest of us. And sometimes the fundamentals can change in the blink of an eye.
These are the to Buy and Outperform analyst calls from Tuesday, May 13, 2025 that included price target hikes or more upside ahead. Please read the disclaimer at the end of this report because no analyst report ever comes with any guarantees.
Caterpillar Inc. (NYSE: CAT) was raised to Outperform from Neutral and its price target was raised to $395 from $309 at Baird. This is actually the same analyst’s second upgrade in the last month. Caterpillar closed at $342.55 on Monday’s surge, up from $325.62 on Friday before the US/China tariff deal news sent its shares higher. The heavy machinery and equipment maker has a 52-week range of $267.30 to $418.50.
First Solar, Inc. (NASDAQ: FSLR) was raised to Outperform from Peer Perform with a $221 price target (versus $156.21 prior close) at Wolfe Research. The solar panel maker may have some protections in the trade deal and the Republican tax bill may not be as bad for existing renewable energy companies as some of the worst fears. First Solar was last seen up at $177 in active trading, and that is up from $140.68 last Friday.
Payoneer Global Inc. (NASDAQ: PAYO) was raised to Outperform from Market Perform and its price target was raised to $9 from $7 at Keefe Bruyette & Woods. Payoneer had been downgraded to Market Perform by KBW just a week earlier around earnings but the stock has since risen more than 10% from its lows. Payoneer was seen trading up 4.5% at $7.50 on Tuesday morning and its 52-week trading range is $5.03 to $11.29.
ALSO READ: THE BIGGEST US/CHINA TRADE DEAL WINNERS ARE…
Peloton Interactive, Inc. (NASDAQ: PTON) was raised to Outperform from Neutral and its price target was lifted up to $10 from $9 (versus $6.64 prior close) at Macquarie. Peloton has a 52-week range of $2.83 to $10.90. Its stock was last seen up almost 2% at $6.77 after the upgrade.
Stanley Black & Decker, Inc. (NYSE: SWK) was upgraded to Overweight from Equal-Weight and its price target was lifted all the way up to $90 from $69 (versus $72.53 prior close) at Barclays. Its 52-week range is $53.91 to $110.88.
Super Micro Computer, Inc. (NASDAQ: SMCI) was started as Outperform with a $41 price target at Raymond James, with the report calling SMCI a market leader in AI-optimized infrastructure at about 70% of its revenue. The firm believes its ability to produce highly customized platforms sets it apart from other OEMs with very competitive price points even if it lacks other service offerings that larger players can offer. SMCI was last seen trading up almost 12% at $37.00 on Tuesday morning, up from $31.99 last Friday before the US/China trade deal was announced.
Terex Corporation (NYSE: TEX) was raised to Outperform from Neutral and its price target was raised to $66 from $48 (versus $44.79 prior close) at Baird. This heavy equipment maker was at $41.18 as of last Friday before the US/China tariff trade deal was announced. Terex was up over 3% at $46.50 on Tuesday after the upgrade and its 52-week range is $31.53 to $68.08.
ALSO READ: IS IT FINALLY WALT DISNEY’S TIME TO SHINE?
Several other analyst calls have been seen this Tuesday as well:
- Aon PLC (NYSE: AON) was raised to Buy from Neutral with a $408 price target (versus $353.57 prior close) at Goldman Sachs. Aon’s 52-week range is $275.07 to $412.97.
- The Charles Schwab Corporation (NYSE: SCHW) was reiterated as Overweight and its price target was raised to $83 from $76 (versus $85.37 prior close) at Morgan Stanley.
- CubeSmart (NYSE: CUBE) was raised to Buy from Neutral with a $50 price objective (versus $42.93 prior close) at BofA Securities.
- Evergy, Inc. (NASDAQ: EVRG) was initiated as Outperform with a $75 price target (versus $65.35 prior close at BMO Capital Markets.
- Insmed Inc. (NASDAQ: INSM) was started as Buy with a $105 price target (versus $67.75 prior close) at Jefferies. Its 52-week range is $21.92 to $84.91.
- Insulet Corporation (NASDAQ: PODD) was raised to Outperform from Neutral with a $350 price target (versus $316.67 prior close) at Wolfe Research.
- PBF Energy Inc. (NYSE: PBF) was raised to Buy from Neutral and its price target was raised to $26 from $20 (versus $20.79 prior close) at UBS. Its 52-week range is $13.62 to $51.63.
- XP Inc. (NYSE: XP) was upgraded to Overweight from Equal-Weight and its price target was raised to $24 from $18 (versus $17.90 prior close) at Morgan Stanley.
Please note that all analyst ratings and the price targets mentioned in this report were issued by each firm named above. Those are their ratings and targets and they may differ greatly from firm to firm. Oggonomics does not issue any formal ratings and price targets of its own on these stocks. Investing involves significant risks, and no analyst reports, even those with very strong conviction, ever come with any guarantees of profits. These research reports also never issue any money-back guarantees in case you lose money.
